Twitter Beğeni Hilesi

The ENZAMET (Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic #ProstateCancer) trial investigated the effects of adding enzalutamide to first-line treatment that included testosterone suppression with or without early docetaxel. #ASCO19

#ENZAMET: Slides available here on ANZUP web site: anzup.org.au/docview.aspx?i… Paper here: nejm.org/doi/full/10.10… NEJM Thanks to the cast of thousands Christopher Sweeney, MBBS NHMRC CTC CCTG CancerTrialsIreland 🌈 Dana-Farber☝️and our selfless patients. #ASCO19

Nice session on rare breast cancer subtypes this morning @asco. Good: ER+ tubular, mucinous; ER neg with interesting chromosomal abnormalities include medullary, mucoepidermoid, secretory, adenoid cystic. Not so good: micropapillary.

Yoland Antill’s PHAEDRA phase 2 trial of durvalumab in metastatic endometrial cancer. Objective tumour responses in 15/35 MMR deficient, 1/36 MMR proficient. Great Team effort w ANZGOG NHMRC CTC Peey Sei Kok Linda Mileshkin @redheadkristy #ASCO19 #AussieOnPodium

Still need to think of that pMMR tumours- how can we make them immune sensitive???

ASCO 2019 ascopost.com/videos/2019-as…

Vale to an amazing man lynchcancers.com/lynch-syndrome…

A fantastic read- couldn’t put it down

Australia is on track to be the first country to eradicate cervical cancer | The New Daily thenewdaily.com.au/news/2019/07/0…

I’m trekking the Larapinta Trail to raise money for WomenCan! Please support me in whatever way you can. womencan-larapinta-2022.raisely.com/yoland-antill #WomenCanLarapinta2022 via Raisely